NIH Nanotechnology Task Force and the NIH Nanomedicine Roadmap Initiative Host Nanoweek 2009
News Apr 03, 2009
NIH's first-of-a-kind series of events focusing on science at the nanoscale, NanoWeek 2009 will include symposia with experts in the field, demonstrations, talks, and posters from NIH scientists.
NanoWeek 2009's first day will include seminars explaining the basic concepts of nanotechnology, followed by summaries of current research being conducted and medical applications of nanotechnology. Speakers include:
-- Dr. Michael Gottesman, deputy director of Intramural Research at the National Institutes of Health
-- Dr. Richard Fisher, associate director for Science Policy and Legislation at the National Eye Institute
-- Dr. Catherine Lewis, director, Division of Cell Biology and Biophysics at the National Institute of General Medical Sciences
-- Dr. Piotr Grodzinski, director of the Nanotechnology in Cancer Program at the National Cancer Institute,
-- Dr. Karen Peterson, senior advisor to the Director of the National Institute of Biomedical Imaging and Bioengineering will also provide remarks.
On Wednesday, NIH scientists will discuss ongoing nanotechnology research being performed at the NIH, along with more than 30 posters presenting work from NIH's labs. There will be afternoon tours of nanotechnology labs at the National Heart, Lung, and Blood Institute, the National Cancer Institute, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute of Biomedical Imaging and Bioengineering, and the National Institute of Neurological Disorders and Stroke.
In coordination with IEEE, a leading professional association for the advancement of technology, NIH will conduct a workshop on Nanomedicine on Thursday and Friday. This will provide an opportunity for engineers and physical scientists to exhibit their cutting-edge technology, as well as to learn about possible biological applications for these technologies. Regulatory and intellectual property aspects of nanoresearch will also be addressed, in combination with presentations from some of the major industry efforts in the field.
Events on Tuesday and Wednesday are open to the public and free of charge. Registration for the lab tours will open on April 1. The nanomedicine workshop on Thursday and Friday requires registration, which is located at https://roan2.wustl.edu/. The full week's agenda, as well as further information on NanoWeek 2009, can be found at http://www.capconcorp.com/nanoweek2009/. For more information on nanotechnology at the National Institutes of Health, see the Web site http://www.nibib.nih.gov/Research/NIHNano.
Combating Cancer by Targeting Sugar ReceptorsNews
Globally, cancer is the second leading cause of death, also because the efficiency of chemotherapeutics is inadequate due to poor delivery to the tumor. Prof. Olivia Merkel and her team develop targeted nanocarrier systems to increase the delivery rates of therapeutic formulations and their specific uptake into the target cells.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018